Furthermore, the upregulation of GRP78 in both tumor cells and the tumor-supporting stromal cells, as an adaptive response to stress, could represent a major obstacle to therapeutic efficacy4, 5, 17, 18, 19. The gene discussed is HSPA5; the disease is neoplasm.